In Managing Hypoglycemia (low blood sugar) Balila 25mg Capsule is used to manage low blood sugar levels, called hypoglycemia. This medicine helps to regulate the blood sugar and restores the condition of the patient to normal. However, Balila 25mg Capsule should not be used to treat low blood sugar from poor nutrition/diet (functional hypoglycemia).The effect of this medicine begins within an hour and generally lasts no more than eight hours in the presence of normal kidney (renal) function. Low blood sugar levels can also be dangerous. Avoid missing a meal, do not exercise too much, and eat enough food to prevent very low blood sugar levels. This will ensure that you do not go into a state of severe hypoglycemia and improves your quality of life.
It is not known whether it is safe to consume alcohol with Balila 25mg Capsule. Please consult your doctor.
Balila 25mg Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Balila 25mg Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
It is not known whether Balila 25mg Capsule alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Balila 25mg Capsule should be used with caution in patients with kidney disease. Dose adjustment of Balila 25mg Capsule may be needed. Please consult your doctor.
There is limited information available on the use of Balila 25mg Capsule in patients with liver disease. Please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Jolly Healthcare || ₹14.5/tablet (25% cheaper)